The U.K. cash shell Spinnaker Opportunities has agreed to acquire the Israeli cannabis firm Kanabo Research.
This marks the first listing of a cannabis company on London's principal stock market, helping the Israeli company raise funds for innovation and clinical trials.
Spinnaker recently said the agreement allows the Israeli company to bypass traditional listing rules.
The exact value of the reverse takeover was not disclosed.
Today's Best Finance Deals
Andy Morrison, the chairman of Spinnaker, said the deal was "comfortably within" a range of $6 million to $39 million in size, according to Reuters.
Kanabo Chief Executive Officer Avihu Tamir said earlier this year that he expected to enter unsaturated markets such as the London Stock Exchange instead of other stock markets where cannabis stocks have a bigger presence.
Kanabo products do not contain THC and are delivered by vaping devices.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!